Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-08-09

Clinical Trial Update: Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial investigated the effect of dopamine infusion on insulin secretion in healthy subjects; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dopamine (dopamine)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Hyperglycemia, Sepsis | Phase 1 | Status: COMPLETED